Michael McCaughan
Latest From Michael McCaughan
Need Advice About Advisory Committees, US FDA? Try Having Some
FDA’s drug center has all but stopped holding meetings at this point, which begs the question: why do they want advice on how to make them better?
US FDA Wants Advice About Advisory Committees: Try Having Some?
The FDA’s drug center has all but stopped holding meetings at this point, which begs the question: why do they want advice on how to make them better?
First Do No Harm: US MedPAC Wrestles With Complexity Of Low-Cost Drug Pricing
The US Medicare Payment Advisory Commission is analyzing two of the lower-cost segments of the US medicine marketplace: generic drugs and the 340B brand discount program. In both cases, there is a picture of complexity and unintended consequences to rival higher cost segments.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
The Aspirin Test For AI?
US FDA Commissioner Robert Califf tells Congress that regulators don’t have to know how artificial intelligence works in medicine, but must make very sure it actually does work.
The Aspirin Test For AI?
US FDA Commissioner Robert Califf tells Congress that regulators don’t have to know how artificial intelligence works in medicine, but must make very sure it actually does work.